Skip to main content
Equibles

Propel Bio Management, LLC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1969764 LOS ANGELES, CA
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,396,384
+$2,049,853 QoQ
Shares Held
1,050,358
+24.9% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
5.96%
of 13F equity value
Holder Rank
#19
of 161 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 76% Shared 24% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Propel Bio Management, LLC holds $132,912,353 across 24 Biotechnology names. PHAT ranks #3 (8.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACHV
Achieve Life Sciences, Inc.
 4,034,018 $26,342,137
2 CORT
Corcept Therapeutics Inc
 136,499 $11,868,588
3 PHAT
Phathom Pharmaceuticals, Inc.
This page 		1,050,358 $11,396,384
4 MIST
Milestone Pharmaceuticals Inc.
 7,429,590 $9,955,650
5 KYTX
Kyverna Therapeutics, Inc.
 883,198 $7,869,294
6 ARTV
Artiva Biotherapeutics, Inc.
 696,436 $6,755,429
7 ABEO
Abeona Therapeutics Inc.
 983,070 $6,075,372
8 PALI
Palisade Bio, Inc.
 2,582,388 $5,397,190

All Filings in PHAT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,396,384 1,050,358
2026-03-31 $9,346,531 841,272
2025-12-31 $12,291,829 740,918
2025-09-30 $6,507,950 552,927
2025-06-30 $8,850,869 922,927
2025-03-31 $7,115,992 1,134,927
2024-12-31 $8,038,207 989,927
2024-09-30 $15,728,280 869,927
2024-06-30 $8,960,248 869,927
2024-03-31 $9,238,624 869,927
2023-12-31 $4,045,019 443,047